Nov 6, 2021 | medical News
Pfizer says that its easy-to-administer Covid-19 pill reduced the risk of hospitalization or death by 89%, in a clinical trial that tested the drug in adults with the disease who were also in high-risk health groups. The oral medicine, with the brand name Paxlovid,...
